Clinical Trials
48 trialsNCT02206334 2026-05-07
Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Breast Cancer, Non-small Cell Lung Cancer, or Prostate Cancer
NRG Oncology
Phase 1 Completed
NCT02837263 2026-05-01
PI Pembro in Combination With Stereotactic Body Radiotherapy for Liver Metastatic Colorectal Cancer
University of Wisconsin, Madison
Phase 1 Completed
NCT00872625 2026-04-23
Radiation Therapy and Docetaxel Followed by Standard Therapy in Treating Women With Breast Cancer
Centre Antoine Lacassagne
Phase 1 Completed
NCT02858869 2026-03-09
Pembrolizumab and Stereotactic Radiosurgery for Melanoma or Non-Small Cell Lung Cancer Brain Metastases
Emory University
Phase 1 Completed
NCT04474353 2025-12-26
Study of Tumor Treating Fields With Hypofractionated Chemoradiotherapy in Newly Diagnosed Glioblastoma
Stanford University
Phase 1 Completed
NCT03807765 2025-12-04
Stereotactic Radiation and Nivolumab in the Management of Metastatic Breast Cancer Brain Metastases
H. Lee Moffitt Cancer Center and Research Institute
Phase 1 Completed
NCT02599454 2025-10-27
Atezolizumab and Stereotactic Body Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer
University of California, Davis
Phase 1 Completed
NCT03325634 2025-10-23
Stereotactic Body Radiation Therapy in Treating Patients With Recurrent Primary Ovarian or Uterine Cancer
University of Colorado, Denver
Phase 1 Completed
NCT03635164 2025-06-27
Radiotherapy With Durvalumab Prior to Surgical Resection for HPV Negative Squamous Cell Carcinoma
University of Colorado, Denver
Phase 1 Completed
NCT01703507 2025-05-16
Phase I Study of Ipilimumab Combined With Whole Brain Radiation Therapy or Radiosurgery for Melanoma
Thomas Jefferson University
Phase 1 Completed
NCT02186509 2025-04-30
Alisertib and Fractionated Stereotactic Radiosurgery in Treating Patients With Recurrent High Grade Gliomas
Thomas Jefferson University
Phase 1 Completed
NCT03812549 2025-03-04
Safety and Tolerability Evaluation of Sintilimab in Combination With Radiation in Stage IV NSCLC Patients
Sichuan University
Phase 1 Completed
NCT05053737 2025-02-03
Radiotherapy in Combination With Atezolizumab Prior to Surgical Resection for HPV Unrelated HNSCC
University of Colorado, Denver
Phase 1 Completed
NCT02643498 2024-12-20
A Dose Escalation Trial of Stereotactic Body Radiotherapy (SBRT) After Induction Chemotherapy for Locally Advanced Pancreatic Cancer
Memorial Sloan Kettering Cancer Center
Phase 1 Completed
NCT05169957 2024-11-05
Hepatic Ablation of Melanoma Metastases to Enhance Immunotherapy Response, a Phase I Clinical Trial (HAMMER I)
University of Michigan Rogel Cancer Center
Phase 1 Completed
NCT01899989 2024-10-04
Stereotactic Body Radiation Therapy for Inoperable Locally-advanced Non-small Cell Lung Cancer
Memorial Sloan Kettering Cancer Center
Phase 1 Completed
NCT03835533 2024-04-12
PORTER
Parker Institute for Cancer Immunotherapy
Phase 1 Completed
NCT00944528 2023-10-27
RSU
Duke University
Phase 1 Completed
NCT03493789 2023-10-18
Fludeoxyglucose F-18-PET in Planning Lung Cancer Radiation Therapy
Emory University
Phase 1 Completed
NCT01068327 2023-10-10
Stereotactic Radiation, Nelfinavir Mesylate & Neoadjuvant Chemotherapy in Locally Advanced Pancreatic Cancer
University of Nebraska
Phase 1 Completed
NCT03452332 2023-09-13
Stereotactic Body Radiation Therapy, Tremelimumab and Durvalumab in Treating Participants With Recurrent or Metastatic Cervical, Vaginal, or Vulvar Cancers
M.D. Anderson Cancer Center
Phase 1 Completed
NCT04205357 2023-03-03
SAS-GKRS
Haukeland University Hospital
Phase 1 Completed
NCT03431948 2023-02-16
C4-MOSART
University of Chicago
Phase 1 Completed
NCT02158234 2023-01-19
Stereotactic Body Radiotherapy and Concurrent Cisplatin for Re-Irradiation of Unresectable, Recurrent Squamous Cell Carcinomas of Head and Neck
H. Lee Moffitt Cancer Center and Research Institute
Phase 1 Completed
NCT02572284 2023-01-19
Dose Escalation Study of Preoperative SBRT for High Risk Prostate Cancer
H. Lee Moffitt Cancer Center and Research Institute
Phase 1 Completed
NCT03122496 2022-06-08
Immunotherapy and Stereotactic Body Radiotherapy (SBRT) for Metastatic Anaplastic Thyroid Cancer
Memorial Sloan Kettering Cancer Center
Phase 1 Completed
NCT01918644 2022-06-01
Neoadjuvant SBRT With Concomitant Capecitabine in Resectable Pancreatic Cancer
University of Wisconsin, Madison
Phase 1 Completed
NCT02653248 2022-02-09
SBRT for Organ Confined Prostate Cancer
Northwell Health
Phase 1 Completed
NCT02716948 2021-11-30
SRS and Nivolumab in Treating Patients With Newly Diagnosed Melanoma Metastases in the Brain or Spine
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 1 Completed
NCT02507765 2021-10-13
Stereotactic Body Radiation Therapy and Transarterial Chemoembolization in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery
Ohio State University Comprehensive Cancer Center
Phase 1 Completed
NCT02239900 2020-11-30
Ipilimumab and Stereotactic Body Radiation Therapy (SBRT) in Advanced Solid Tumors
M.D. Anderson Cancer Center
Phase 1 Completed
NCT01162200 2020-08-20
Cyberknife® Partial Breast Irradiation (PBI) for Early Stage Breast Cancer
University of Texas Southwestern Medical Center
Phase 1 Completed
NCT02946008 2019-11-27
Neoadjuvant Stereotactic Body Radiotherapy Prior to Radical Prostatectomy for High Risk Prostate Cancer
University of Michigan Rogel Cancer Center
Phase 1 Completed
NCT01392209 2019-11-22
Hypofractionated Stereotactic Radiotherapy With Bevacizumab in the Treatment of Recurrent Malignant Glioma
Memorial Sloan Kettering Cancer Center
Phase 1 Completed
NCT02298946 2019-02-22
AMP-224, a PD-1 Inhibitor, With Stereotactic Body Radiation Therapy in Metastatic Colorectal Cancer
National Institutes of Health Clinical Center (CC)
Phase 1 Completed
NCT00547677 2019-02-15
Stereotactic Radiosurgery for Patients With Hepatic Metastases.
University of Texas Southwestern Medical Center
Phase 1 Completed
NCT00567970 2018-10-09
Stereotactic Radiation Therapy in Treating Patients With Liver Metastases
Mayo Clinic
Phase 1 Completed
NCT00837928 2018-05-17
Bendamustine and Radiation Therapy in Treating Patients With Brain Metastases Caused by Solid Tumors
Ohio State University Comprehensive Cancer Center
Phase 1 Completed
NCT01252797 2018-05-14
RAD 1002
University of Alabama at Birmingham
Phase 1 Completed
NCT00547131 2018-04-17
Temozolomide in Treating Patients With Primary Brain Tumors or Metastatic Brain Tumors
City of Hope Medical Center
Phase 1 Completed
NCT01276210 2017-07-17
Sorafenib Tosylate and Stereotactic Radiosurgery in Treating Patients With Brain Metastases
Vanderbilt-Ingram Cancer Center
Phase 1 Completed
NCT01668134 2017-02-20
Stereotactic Body Radiotherapy for Hepatocellular Carcinoma, and Intrahepatic Cholangiocarcinoma
Washington University School of Medicine
Phase 1 Completed
NCT02406183 2017-01-10
Trial of SBRT With Concurrent Ipilimumab in Metastatic Melanoma
University Hospital, Ghent
Phase 1 Completed
NCT01446458 2016-03-22
Phase I Study of Stereotactic Body Radiation Therapy and FOLFIRINOX in the Neoadjuvant Therapy of Pancreatic Cancer
Emory University
Phase 1 Completed
NCT01652794 2015-08-04
Carboplatin, Gemcitabine Hydrochloride, and Stereotactic Body Radiation Therapy in Gynecological Cancer
Case Comprehensive Cancer Center
Phase 1 Completed
NCT00004262 2013-06-04
Radiation Therapy and Gadolinium Texaphyrin in Treating Patients With Supratentorial Glioblastoma Multiforme
National Cancer Institute (NCI)
Phase 1 Completed
NCT00230347 2010-04-01
Evaluation of Stereotactic Radiosurgery For Liver Malignancies
Stanford University
Phase 1 Completed
NCT00185861 2009-04-09
Phase I Trial of Arsenic Trioxide and Stereotactic Radiotherapy for Recurrent Malignant Glioma
Stanford University
Phase 1 Completed